#     time ref_word        asr_output      
D     0.00 Novartis        -               
D     0.00 says            -               
D     0.00 it              -               
D     0.00 will            -               
D     0.00 stick           -               
D     0.00 with            -               
D     0.00 drug            -               
D     0.00 development     -               
S     0.03 in              @bg             
D     2.09 India           -               
C     2.10 Swiss           Swiss           
C     2.35 drugs           drugs           
C     2.71 maker           maker           
C     2.98 Novartis        Novartis        
C     3.76 -               @bg             
C     3.77 says            says            
C     4.04 its             its             
C     4.24 Indian          Indian          
C     4.75 subsidiary      subsidiary      
C     5.45 will            will            
C     5.61 continue        continue        
C     6.09 to              to              
C     6.18 file            file            
C     6.57 -               @bg             
C     6.58 patents         patents         
C     7.11 for             for             
C     7.20 new             new             
C     7.43 drugs           drugs           
C     7.82 -               @bg             
C     7.83 in              in              
C     7.96 India           India           
C     8.29 -               @bg             
C     8.69 -               @bg             
C     8.81 despite         despite         
C     9.42 -               @bg             
C     9.43 the             the             
C     9.52 rejection       rejection       
C     9.99 of              of              
C    10.08 -               @bg             
C    10.09 its             its             
C    10.27 plea            plea            
C    10.54 for             for             
C    10.64 patent          patent          
C    11.01 -               @bg             
C    11.02 protection      protection      
C    11.54 for             for             
C    11.64 its             its             
C    11.86 anti            anti            
C    12.22 cancer          cancer          
I    12.66 -               drug            
C    12.95 -               @bg             
I    12.96 -               PG              
S    13.21 treatment       Lech            
C    13.62 -               @bg             
C    14.20 -               @bg             
C    14.46 -               @bg             
S    14.60 Gilvec          Novartis        
S    15.14 Novartis'       is              
C    15.29 seven           seven           
C    15.57 year            year            
C    15.75 -               @bg             
C    15.76 legal           legal           
C    16.07 battle          battle          
C    16.43 failed          failed          
C    16.89 after           after           
C    17.18 India's         India's         
C    17.48 Supreme         Supreme         
C    17.86 Court           Court           
C    18.15 -               @bg             
C    18.16 ruled           ruled           
C    18.41 it              it              
D    18.54 was             -               
D    18.54 it              -               
C    18.55 was             was             
C    18.68 an              an              
C    18.79 -               @bg             
C    18.80 amended         amended         
C    19.29 version         version         
C    19.73 -               @bg             
C    20.18 of              of              
C    20.36 an              an              
C    20.43 existing        existing        
C    21.18 -               @bg             
C    21.22 -               @bg             
C    21.23 compound        compound        
C    21.88 -               @bg             
C    22.09 -               @bg             
C    22.23 we              we              
C    22.45 will            will            
C    22.86 -               @bg             
C    23.02 continue        continue        
C    23.75 -               @bg             
I    24.14 -               our             
C    24.50 with            with            
C    24.64 our             our             
C    24.75 investments     investments     
C    25.36 in              in              
C    25.57 -               @bg             
C    25.64 India           India           
C    26.09 -               @bg             
C    26.31 -               @bg             
C    26.32 even            even            
C    26.55 though          though          
C    26.68 cautiously      cautiously      
C    27.41 -               @bg             
C    28.71 new             new             
C    28.98 products        products        
I    29.64 -               are             
C    29.93 -               @bg             
C    29.98 which           which           
S    30.25 we              relaunched      
C    30.93 -               @bg             
C    31.20 -               @bg             
S    31.32 launched        are             
C    31.61 -               @bg             
C    31.75 we              we              
C    31.96 will            will            
C    32.16 ask             ask             
C    32.39 -               @bg             
C    32.40 for             for             
S    32.53 patents         patterned       
C    32.97 -               @bg             
C    32.98 for             for             
C    33.10 these           these           
C    33.30 products        products        
C    33.90 -               @bg             
I    34.76 -               of              
C    35.10 -               @bg             
I    35.28 -               a               
S    35.38 and             new             
S    35.67 we              pope            
C    35.95 -               @bg             
S    36.42 hope            are             
C    36.78 that            that            
C    36.99 the             the             
C    37.09 ecosystem       ecosystem       
C    38.02 -               @bg             
C    38.70 for             for             
C    39.05 intellectual    intellectual    
C    39.55 property        property        
C    40.16 -               @bg             
C    40.45 -               @bg             
I    40.59 -               part            
C    41.03 in              in              
C    41.12 the             the             
C    41.23 country         country         
C    41.73 improves        improves        
C    42.42 -               @bg             
C    42.61 -               @bg             
C    42.62 clearly         clearly         
C    42.99 we              we              
C    43.09 are             are             
C    43.19 disappointed    disappointed    
C    43.91 -               @bg             
C    44.12 with            with            
C    44.28 the             the             
C    44.38 decision        decision        
D    44.98 said            -               
D    44.98 Novartis        -               
D    44.98 India           -               
D    44.98 managing        -               
D    44.98 Director        -               
S    44.98 Ranjit          @bg             
S    45.37 Shahani         @bg             
C    45.49 many            many            
C    45.80 drugs           drugs           
C    46.17 firms           firms           
C    46.72 -               @bg             
C    46.73 seek            seek            
C    46.97 to              to              
C    47.05 extend          extend          
C    47.51 their           their           
C    47.70 patents         patents         
C    48.16 by              by              
C    48.30 making          making          
C    48.66 minor           minor           
C    49.01 compound        compound        
C    49.48 changes         changes         
C    50.16 -               @bg             
C    50.45 a               a               
C    50.57 -               @bg             
C    50.58 process         process         
C    51.02 known           known           
C    51.22 as              as              
C    51.40 evergreening    evergreening    
C    52.02 -               @bg             
C    52.45 -               @bg             
C    52.56 it              it              
C    52.72 -               @bg             
C    52.73 prevents        prevents        
C    53.19 cheaper         cheaper         
C    53.66 generic         generic         
C    54.13 versions        versions        
C    54.70 from            from            
C    54.88 being           being           
C    55.13 sold            sold            
C    55.70 -               @bg             
S    56.38 it's            @bg             
S    56.66 hugely          League          
C    56.99 significant     significant     
C    57.60 because         because         
C    57.82 -               @bg             
C    57.83 eight           eight           
C    58.02 million         million         
C    58.27 people          people          
I    58.52 -               in              
C    58.63 with            with            
C    58.77 HIV             HIV             
C    59.27 are             are             
C    59.45 on              on              
C    59.72 treatment       treatment       
C    60.23 from            from            
C    60.48 India           India           
C    60.74 -               @bg             
C    61.15 -               @bg             
C    61.16 more            more            
C    61.34 than            than            
C    61.45 eighty          eighty          
C    61.66 percent         percent         
C    62.16 of              of              
C    62.30 these           these           
I    62.45 -               eight           
I    62.59 -               million         
C    62.84 people          people          
C    63.12 get             get             
S    63.27 these           the             
C    63.38 drugs           drugs           
C    63.69 from            from            
C    63.90 India           India           
I    64.14 -               and             
C    64.33 -               @bg             
I    64.36 -               so              
I    64.64 -               for             
C    64.77 -               @bg             
C    64.78 in              in              
C    64.91 the             the             
C    64.97 area            area            
C    65.25 of              of              
I    65.33 -               a               
C    65.49 -               @bg             
S    65.50 HIV             timely          
C    66.16 this            this            
C    66.31 decision        decision        
C    66.75 is              is              
C    66.89 path            path            
C    67.14 breaking        breaking        
C    67.49 -               @bg             
C    67.50 -               @bg             
C    67.56 number          number          
C    67.80 -               @bg             
C    67.81 two             two             
C    67.98 is              is              
C    68.17 this            this            
C    68.52 -               @bg             
C    69.34 by              by              
C    69.55 protecting      protecting      
C    70.05 generic         generic         
C    70.41 competition     competition     
C    71.08 and             and             
C    71.31 -               @bg             
C    71.34 abusive         abusive         
C    71.73 practices       practices       
C    72.33 of              of              
C    72.62 -               @bg             
C    72.78 pharma          pharma          
C    73.02 companies       companies       
C    73.38 like            like            
S    73.53 Novartis        martyrs         
C    74.19 -               @bg             
C    74.41 -               @bg             
C    74.81 I               I               
C    74.94 think           think           
C    75.08 the             the             
C    75.17 Supreme         Supreme         
C    75.52 -               @bg             
C    75.53 Court           Court           
C    75.77 has             has             
C    75.89 safeguarded     safeguarded     
C    76.34 the             the             
C    76.41 rights          rights          
C    76.72 of              of              
C    76.81 patients        patients        
C    77.22 across          across          
C    77.53 the             the             
C    77.59 developing      developing      
D    77.98 world           -               
D    77.98 said            -               
D    77.98 Neena           -               
D    77.98 Manghaney       -               
D    77.98 of              -               
D    77.98 doctors         -               
S    77.98 without         wife            
S    79.05 borders         @bg             
C    79.06 this            this            
C    79.25 patients        patients        
C    79.77 -               @bg             
C    79.78 before          before          
C    80.11 patents         patents         
C    80.52 -               @bg             
C    80.53 approach        approach        
C    80.94 is              is              
C    81.09 getting         getting         
C    81.39 support         support         
C    81.78 from            from            
C    81.94 health          health          
C    82.27 services        services        
C    82.81 facing          facing          
C    83.25 cuts            cuts            
C    83.62 and             and             
C    83.84 rising          rising          
C    84.33 drugs           drugs           
C    84.64 bills           bills           
C    85.08 and             and             
C    85.28 consumers       consumers       
C    85.81 alike           alike           
C    86.27 -               @bg             
C    86.28 -               @bg             
C    86.78 -               @bg             
C    86.89 but             but             
C    87.05 -               @bg             
C    87.06 hitting         hitting         
C    87.30 the             the             
C    87.39 drugs           drugs           
C    87.66 -               @bg             
C    87.67 developers'     developers'     
C    88.20 profits         profits         
C    88.80 and             and             
I    89.06 -               worn            
C    89.33 analysts        analysts        
D    89.89 warn            -               
D    89.89 it              -               
C    89.89 may             may             
C    90.02 -               @bg             
C    90.03 dissuade        dissuade        
C    90.47 innovation      innovation      
C    90.96 -               @bg             
C    90.97 in              in              
C    91.05 the             the             
C    91.14 long            long            
C    91.36 term            term            
C    91.64 -               @bg             
# u: 253 e: 58 s: 22 i: 15 d: 21 c: 210 ua: 77.08% pc: 83.00% uer: 22.92%
# U: 253 E: 58 S: 22 8.70% I: 15 5.93% D: 21 8.30% C: 210 83.00% UA: 77.08% UER: 22.92%
